| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.23 | 0.0002 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |